1. The Magic Flute is a Singspiel, not an opera? My thoughts about the German, Austrian and Swiss Guidelines for Systemic Treatment of Gastric Cancer

   • Yasuhiro Kodera

   Editorial 13 October 2023 Pages: 1 - 2

2. National guidelines for gastric cancer: redundant or needed?

   • Florian Lordick
   • Bernhard Wörmann

   Editorial Open access 17 October 2023 Pages: 3 - 5

3. German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer

   • Florian Lordick
   • Salah-Eddin Al-Batran
   • For the Germany Society of Hematology and Medical Oncology (DGHO, Austrian Society of Hematology and Oncology (OeGHO), Swiss Society of Hematology (SSH), Swiss Society of Medical Oncology (SGMO); in collaboration with the Arbeitsgemeinschaft Internistische Onkologie (AIO) of the German Cancer Society

   Special Article Open access 17 October 2023 Pages: 6 - 18

   

4. Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations

   • Sangjun Lee
   • Sue K. Park

   Original Article 02 November 2023 Pages: 19 - 27

   

5. Helicobacter pylori testing prior to or at gastric cancer diagnosis and survival in a diverse US patient population

   • Katherine S. Garman
   • HannahSofia Brown
   • Meira Epplein

   Original Article 20 November 2023 Pages: 28 - 35

   

6. Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study)

   • Takuji Gotoda
   • Hideki Ishikawa
   • Yutaka Matsuyama

   Original Article 25 November 2023 Pages: 36 - 48

   

7. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation

   • Rongjun Xie
   • Longfei Liu
   • Guoxin Li

   Original Article Open access 28 October 2023 Pages: 49 - 71

   

8. Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response

   • Bianca Grosser
   • Christian M. Heyer
   • Bruno Märkl

   Original Article Open access 24 October 2023 Pages: 72 - 85

   

9. Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy

   • Bingzhi Wang
   • Yongjian Zhu
   • Liyan Xue

   Original Article 29 November 2023 Pages: 86 - 101

   

10. Effect of preoperative chemotherapy on the histopathological classification of gastric cancer

    • I. A. Caspers
    • H. D. Biesma
    • N. C. T. van Grieken

    Original Article Open access 10 November 2023 Pages: 102 - 109

    

11. DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 PRODIGY trial

    • Jaewon Hyung
    • Hyungwoo Cho
    • Yoon-Koo Kang

    Original Article 27 October 2023 Pages: 110 - 117

    

12. Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study

    • Choong-kun Lee
    • Jii Bum Lee
    • Sun Young Rha

    Original Article 31 October 2023 Pages: 118 - 130

    

13. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry

    • Pablo Pérez-Wert
    • Ana Custodio
    • the AGAMENON-SEOM study group

    Original Article 15 November 2023 Pages: 131 - 145

    

14. Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy

    • Eo Jin Kim
    • Heejung Chae
    • Yoon-Koo Kang

    Original Article 25 November 2023 Pages: 146 - 154

    

15. 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer

    • Takaki Yoshikawa
    • Masanori Terashima
    • Mitsuru Sasako

    Original Article 21 November 2023 Pages: 155 - 163

    

16. A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401

    • Chikara Kunisaki
    • Hitoshi Katai
    • the Stomach Cancer Study Group of Japan Clinical Oncology Group

    Original Article 25 October 2023 Pages: 164 - 175

    

17. Identifying the best candidates for reduced port gastrectomy

    • Jae Hun Chung
    • Jawon Hwang
    • Hyoung-Il Kim

    Original Article Open access 24 October 2023 Pages: 176 - 186

    

18. Automatic surgical phase recognition-based skill assessment in laparoscopic distal gastrectomy using multicenter videos

    • Masaru Komatsu
    • Daichi Kitaguchi
    • Masaaki Ito

    Original Article 01 December 2023 Pages: 187 - 196